LEADER 01867oam  2200421Ia 450 
001 9910697548103321
005 20080918161437.0
035   $a(CKB)5470000002389472
035   $a(OCoLC)76790551
035   $a(EXLCZ)995470000002389472
100   $a20061122d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTrends in the use and expenditures for COX-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs, 1997-2003$b[electronic resource] /$fJessica Banthin and Marc Zodet
210  1$a[Rockville, Md.] :$cMedical Expenditure Panel Survey, Agency for Healthcare Research and Quality,$d[2006]
215   $a6 unnumbered pages $cdigital, PDF file
225 1 $aStatistical brief ;$v#139
300   $aTitle from title screen (viewed Sept. 18, 2008).
300   $a"September 2006."
320   $aIncludes bibliographical references.
330   $aThis Statistical Brief uses data from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC) to document trends in use and expenditures for COX-2 inhibitors from 1997 to 2003 in relation to trends for traditional NSAIDS.
606   $aNonsteroidal anti-inflammatory agents
606   $aCyclooxygenase 2$xInhibitors
615  0$aNonsteroidal anti-inflammatory agents.
615  0$aCyclooxygenase 2$xInhibitors.
700   $aBanthin$b Jessica S$01399465
712 02$aUnited States.$bAgency for Healthcare Research and Quality.
712 02$aMedical Expenditure Panel Survey (U.S.)
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697548103321
996   $aTrends in the use and expenditures for COX-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs, 1997-2003$93539072
997   $aUNINA